Latest stories on VYLR
VYLR Maintained by UBS -- Price Target Lowered to $87.00
GuruFocus38 · neutralanalyst
Vylor Inc. (VYLR) Q3 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
Vylor Inc. (VYLR) files 8-K: Items 2.02, 9.01
SEC 8-K50 · neutralgeneral
Vylor Inc. (VYLR) files 8-K: Item 9.01
SEC 8-K50 · neutralgeneral
Vylor (VYLR) Reports Q3 Revenues Slightly Below Expectations Amid Strategic Separation Completion
GuruFocus42 · neutralearnings
Vylor Inc (VYLR) Reports Positive Agricultural Sector Trends Amid Steady Growth Outlook
GuruFocus58 · neutralgeneral
Vylor Inc. (VYLR) Reports Q3 Earnings Beat Amid Slight Revenue Decline
GuruFocus58 · neutralearnings
Vylor Inc. Non-GAAP EPS of -$0.42 beats by $0.10, revenue of $938M beats by $19.94M
Business Insider64 · neutralearnings
Is Wall Street Bullish or Bearish on Vylor Stock?
Barchart50 · neutralanalyst
Vylor Inc. declares $0.13 dividend
Seeking Alpha52 · neutralgeneral
VYLR - Vylor Stock Price
Barchart50 · neutralgeneral
Vylor declares a $0.13 quarterly dividend with a December 7 payment date
October 23, 2026
MarketChameleon56 · neutralgeneral
Vylor announces new $3B share repurchase program
The Fly74 · bullishgeneral
Vylor Announces $3 Billion Share Repurchase Program
StockTitan74 · bullishgeneral
BNP Paribas Exane initiates Vylor stock with neutral rating at $75
Investing.com Analyst Ratings50 · neutralanalyst
Vylor initiated with a Neutral at BNP Paribas
The Fly50 · neutralanalyst
Vylor: A Food Scarcity Play With Growth Optionality
Seeking Alpha64 · neutralanalyst
Vylor Inc. (VYLR) files 8-K
SEC 8-K50 · neutralgeneral
UBS starts Vylor at Buy, sees upside on seed licensing growth
Seeking Alpha64 · neutralanalyst
Vylor initiated with a Buy at UBS
The Fly63 · neutralanalyst
UBS initiates Vylor stock with buy rating on trait licensing potential
Investing.com Analyst Ratings63 · neutralanalyst
Vylor Inc. (VYLR) files 8-K
SEC 8-K50 · neutralgeneral
Vylor Inc. (VYLR) files 8-K
SEC 8-K50 · neutralm&a
How to Play Newly Listed Vylor (VYLR) Stock After the Corteva Spinoff
Barchart58 · neutralm&a
Vylor rated Outperform in new research coverage at Oppenheimer
Seeking Alpha67 · bullishanalyst